{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:17:09Z","timestamp":1790857029862,"version":"4.1.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,4,7]]},"DOI":"10.3233\/jad-191227","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T11:23:19Z","timestamp":1582629799000},"page":"829-837","source":"Crossref","is-referenced-by-count":46,"title":["The Amyloid, Tau, and Neurodegeneration (A\/T\/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up"],"prefix":"10.1177","volume":"74","author":[{"given":"G\u00f8ril Rolfseng","family":"Gr\u00f8ntvedt","sequence":"first","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology, University Hospital of Trondheim, Trondheim, Norway"},{"name":"Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Lauridsen","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology, University Hospital of Trondheim, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda R.","family":"White","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology, University Hospital of Trondheim, Trondheim, Norway"},{"name":"Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Salvesen","sequence":"additional","affiliation":[{"name":"Unit for Applied Clinical Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Br\u00e5then","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology, University Hospital of Trondheim, Trondheim, Norway"},{"name":"Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid Botne","family":"Sando","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology, University Hospital of Trondheim, Trondheim, Norway"},{"name":"Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-191227_ref1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-191227_ref2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-191227_ref3","doi-asserted-by":"crossref","first-page":"226ra230","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-191227_ref4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-191227_ref5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-191227_ref6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jalz.2018.03.002","article-title":"The National Institute on Aging and the Alzheimer\u2019s Association Research Framework for Alzheimer\u2019s disease: Perspectives from the Research Roundtable","volume":"14","author":"Knopman","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-191227_ref7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-191227_ref8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimers disease Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-191227_ref9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-191227_ref10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State: A practical method for grading the cognitive state of patients for clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychol Res"},{"key":"10.3233\/JAD-191227_ref11","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-191227_ref12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail Making Test as an indication of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"10.3233\/JAD-191227_ref13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/jnnp-2013-307228","article-title":"Apolipoprotein E epsilon2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort","volume":"85","author":"Berge","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-191227_ref14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnagi.2016.00030","article-title":"Cerebrospinal fluid levels of amyloid beta 1\u201343 in patients with amnestic mild cognitive impairment or early Alzheimer\u2019s disease: A 2-year follow-up study","volume":"8","author":"Lauridsen","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-191227_ref15","doi-asserted-by":"crossref","unstructured":"(1994) Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 57, 416\u2013418.","DOI":"10.1136\/jnnp.57.4.416"},{"key":"10.3233\/JAD-191227_ref16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-191227_ref17","first-page":"986310","article-title":"Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid","volume":"2010","author":"Bjerke","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-191227_ref18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jneumeth.2013.03.011","article-title":"Pre-analytical factors influencing the stability of cerebrospinal fluid proteins","volume":"215","author":"Simonsen","year":"2013","journal-title":"J Neurosci Methods"},{"key":"10.3233\/JAD-191227_ref19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JAD-150234","article-title":"Effect of Tween-20 on core biomarkers measured in cerebrospinal fluid from patients with Alzheimer\u2019s disease, mild cognitive impairment, or healthy control individuals","volume":"49","author":"Berge","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-191227_ref20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JAD-150234","article-title":"Effect of Tween-20 on core biomarkers measured in cerebrospinal fluid from patients with Alzheimer\u2019s disease, mild cognitive impairment, or healthy control individuals","volume":"49","author":"Berge","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-191227_ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.3233\/JAD-191227_ref22","doi-asserted-by":"crossref","first-page":"e1635","DOI":"10.1212\/WNL.0000000000008361","article-title":"Applying the ATN scheme in a memory clinic population: The ABIDE project","volume":"93","author":"Altomare","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-191227_ref23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13195-019-0543-7","article-title":"Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes","volume":"11","author":"Carandini","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-191227_ref24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u2013concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-191227_ref25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23931","article-title":"Mild cognitive impairment due to Alzheimer disease in the community","volume":"74","author":"Petersen","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-191227_ref26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2013.147","article-title":"Mild cognitive impairment\u2014amyloid and beyond","volume":"9","author":"Scheltens","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-191227_ref27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ana.24903","article-title":"Outcomes after diagnosis of mild cognitive impairment in a large autopsy series","volume":"81","author":"Abner","year":"2017","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-191227_ref28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-191227_ref29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrneurol.2013.21","article-title":"Alzheimer disease: Abeta-independent processes-rethinking preclinical AD","volume":"9","author":"Chetelat","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-191227_ref30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-191227_ref31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","article-title":"PART is part of Alzheimer disease","volume":"129","author":"Duyckaerts","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-191227_ref32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41374-019-0186-0","article-title":"Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer\u2019s neuropathology","volume":"99","author":"Teylan","year":"2019","journal-title":"Lab Invest"},{"key":"10.3233\/JAD-191227_ref33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-191227_ref34","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1038\/s41598-018-26151-8","article-title":"The A\/T\/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment","volume":"8","author":"Ekman","year":"2018","journal-title":"Sci Rep"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-191227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:48Z","timestamp":1777370868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-191227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":34,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-191227","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}